Anthem Pharmaceuticals is a premier R&D and regulatory services company developing small-molecule therapeutics for the treatment of psoriasis, osteoarthritis, and fatty liver disease.

As a service provider, we follow a “lab-to-market” approach that encompasses all aspects of drug discovery, preclinical and development-stage contract research. Our services include discovery research, CMC, regulatory toxicology/safety assessment, DMPK, analytical R&D, clinical trials, cGMP, and regulatory affairs for the approval of drugs, vaccines, biologics, and medical devices, supported by our global collaborations.

Anthem Pharmaceuticals provides services to a wide range of industries, including biotech, pharmaceuticals, biologics, veterinary, nutraceutical, and cosmetics, adhering to GLP compliance and certification standards of the US FDA, EMA, MHRA, Health Canada, and other regulatory authorities.